Characterising symptom ‘trajectotypes’ in patients with COPD

A. Halner (Oxford (Oxfordshire), United Kingdom), D. Nicolau (Brisbane (Queensland), Australia), M. Bafadhel (Oxford (Oxfordshire), United Kingdom)

Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Session: Personalised treatment of obstructive diseases
Session type: E-poster session
Number: 2670
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Halner (Oxford (Oxfordshire), United Kingdom), D. Nicolau (Brisbane (Queensland), Australia), M. Bafadhel (Oxford (Oxfordshire), United Kingdom). Characterising symptom ‘trajectotypes’ in patients with COPD. 2670

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Drivers of respiratory symptoms in COPD patients
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018


COPD patients
Source: Eur Respir Monogr 2021; 90: 154-164
Year: 2021


Care-continuity for COPD patients
Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences
Year: 2012


Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD
Source: Eur Respir J 2013; 41: 993-995
Year: 2013


The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013


Comparing the prevalence of depression and anxiety in patients admitted with an exacerbation of COPD using two scoring systems
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015


Sexuality in patients with asthma and/or COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 54s
Year: 2003

Cough rate may predict disease severity in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 536s
Year: 2004

Impact of comorbid bronchiectasis on COPD patients
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017


Fatigue perception and related factors in patients with advanced sarcoidosis and COPD patients
Source: International Congress 2017 – The many faces of sarcoidosis
Year: 2017


GERD and anxiety in patients with severe COPD
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011

An exploration of dyspnoea and determinants in patients with COPD
Source: Virtual Congress 2020 – Novel insights into nursing interventions for managing patients with asthma and COPD
Year: 2020




Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


Daily symptom burden in patients with severe COPD
Source: Annual Congress 2010 - Palliative care, oxygen and community care for chronic lung disease
Year: 2010

Catabolic/anabolic balance in patients with COPD exacerbation
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004

The severity of anxiety in COPD patients (pts)
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016


Hospitalisation of COPD patients due to comorbidity
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008


Severe outcomes of COVID-19 among patients with COPD and asthma
Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020
Year: 2021



Gender differences in hospitalized patients with acute exacerbation of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013